「肝胆膵消化器病学」は横浜市立大学附属病院の消化器内科部門です


  1. Honda Y, Imajo K, Kato T, Kessoku T, Ogawa Y, Tomeno W, Kato S, Mawatari H, Fujita K, Yoneda M, Saito S, Nakajima A. The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. PLoS One. 2016 Jan 5;11(1):e0146337. doi: 10.1371/journal.pone.0146337. eCollection 2016．
  2. Honda Y, Yoneda M, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Mawatari H, Fujita K, Hyogo H, Ueno T, Chayama K, Saito S, Nakajima A, Hotta K. The characteristics of non-obese NAFLD: Effect of genetic and environmental factors. Hepatol Res. 2016 Sep;46(10):1011-8. doi: 10.1111/hepr.12648. Epub 2016 Apr 5.
  3. Fujisawa T, Kagawa K, Hisatomi K, Kubota K, Sato H, Nakajima A, Matsuhashi N：Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol. 2016 Sep;51(9):931-8. doi: 10.1007/s00535-016-1160-x. Epub 2016 Jan 20.
  4. Nonaka T, Inamori M, Kanoshima K, Ohkuma K, Inoh Y, Matsuura M, Fuyuki A, Uchiyama S, Higurashi T, Ohkubo H, Iida H, Endo H, Tateishi Y, Kusakabe A, Ohashi K, Maeda S, Nakajima A. Evaluation of endoscopic findings for discriminating between early carcinomas and low-grade adenomas in superficial elevated gastric lesions. Turk J Gastroenterol. 2016 Mar;27(2):108-14. doi: 10.5152/tjg.2015.150359. Epub 2016 Feb 5.
  5. Kessoku T, Imajo K, Honda Y, Kato T, Ogawa Y, Tomeno W, Kato S, Mawatari H, Fujita K, Yoneda M, Nagashima Y, Saito S, Wada K, Nakajima A. Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. Sci Rep. 2016 Feb 25;6:22251. doi: 10.1038/srep22251.
  6. Higurashi T, Hosono K, Takahashi H, Komiya Y, Umezawa S, Sakai E, Uchiyama T, Taniguchi L, Hata Y, Uchiyama S, Hattori A, Nagase H, Kessoku T, Arimoto J, Matsuhashi N, Inayama Y, Yamanaka S, Taguri M, Nakajima A.　 Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. 2016 Apr;17(4):475-83. doi: 10.1016/S1470-2045(15)00565-3. Epub 2016 Mar 3.
  7. Yoneda M, Thomas E, Schiff ER：Reply：Supersonic Shear Imaging and Transient Elastography in obesity. Clin Gastroenterol Hepatol. 2016 Mar;14(3):484-5. doi: 10.1016/j.cgh.2015.12.009. Epub 2015 Dec 9.
  8. Sakai E, Fukuyo M, Matsusaka K, Ohata K, Doi N, Takane K, Matsuhashi N, Fukushima J, Nakajima A, Kaneda A : TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors. Cancer Sci, 2016 Jun;107(6):820-7. doi: 10.1111/cas.12930. Epub 2016 Apr 27.
  9. Tamura K, Kawai Y, Kiguchi T, Okamoto M, Kaneko M, Maemondo M, Gemba K, Fujimaki K, Kirito K, Goto T, Fujisaki T, Takeda K, Nakajima A, Ueda T : Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol. Int J Clin Oncol, 2016 Oct;21(5):996-1003. Epub 2016 Mar 26.
  10. Sekino Y, Nakajima A, Kubota K : Successful endoscopic papillectomy in patient with situs inversus. Dig Endosc. 2016 Jul;28(5):616. doi: 10.1111/den.12662. No abstract available..
  11. Endo H, Kato T, Sakai E, Taniguchi L, Arimoto J, Kawamura H, Higurashi T, Ohkubo H, Nonaka T, Taguri M, Inamori M, Yamanaka T, Sakaguchi T, Hata Y, Nagase H, Nakajima A: Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy? J Gastroenterol. 2017 Feb;52(2):194-202. doi: 10.1007/s00535-016-1212-2. Epub 2016 Apr 19.
  12. Yamada E, Tsunoda S, Abe T, Uchida E, Teraoka H, Watanabe S, Kawana I, Tagri　M, Hosaka N, Nagai K, Nishino H, Nakajima A. Factors associated with poor　therapeutic response in outpatients with irritable bowel syndrome: a multicenter study in Japan. J Gastroenterol. 2017 Mar;52(3):301-307. doi: 10.1007/s00535-016-1215-z. Epub 2016 Apr 29.
  13. Yoneda M, Hyun J, Jakubski S, Saito S, Nakajima A, Schiff ER, Thomas E. Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κB. J Immunol. 2016 Jul 15;197(2):630-43. doi: 10.4049/jimmunol.1502677. Epub 2016 Jun 10.
  14. Kubota K, Hasegawa S, Iwasaki A, Sato T, Fujita Y, Hosono K, Nakajima A, Mori R, Matsuyama R, Endo I: Stent placement above the sphincter of Oddi permits implementation of neoadjuvant chemotherapy in patients with initially unresectable Klatskin tumor. Endosc Int Open. 2016 Apr;4(4):E427-33. doi: 10.1055/s-0042-102246. Epub 2016 Mar 30.
  15. Imajo K, Nakajima A：Reply. Gastroenterology. 2016 Aug;151(2):375-6. doi: 10.1053/j.gastro.2016.06.046. Epub 2016 Jul 1. No abstract available.
  16. Arimoto J, Horita N, Kato S, Fuyuki A, Higurashi T, Ohkubo H, Endo H, Takashi N, Kaneko T, Nakajima A: Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis. Sci Rep. 2016 Jul 15;6:29754. doi: 10.1038/srep29754.
  17. Uchida K, Nakajima A, Ushijima K, Ida S, Seki Y, Kakuta F, Abukawa D, Tsukahara H, Maisawa SI, Inoue M, Araki T, Umeno J, Matsumoto T, Taguchi T. Pediatric Onset Chronic Nonspecific Multiple Ulcers of Small Intestine: A Nationwide Survey and Genetic Study in Japan. J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):565-568. doi: 10.1097/MPG.0000000000001321.
  18. Fujisawa T, Kagawa K, Hisatomi K, Kubota K, Nakajima A, Matsuhashi N. Is endoscopic papillary balloon dilatation really a risk factor for post-ERCP pancreatitis? World J Gastroenterol. 2016 Jul 14;22(26):5909-16. doi: 10.3748/wjg.v22.i26.5909. Review.
  19. Kudo C, Kessoku T, Kamata Y, Hidaka K, Kurihashi T, Iwasaki T, Takashiba S, Kodama T, Tamura T, Nakajima A, Minabe M : Relationship between non-alcoholic fatty liver disease and periodontal disease: a review and study protocol on the effect of periodontal treatment on non-alcoholic fatty liver disease. Journal of Translational Science. 2016 Volume 2(6): 340-345. doi: 10.15761/JTS.1000160.
  20. Fujita Y, Iwasaki A, Sato T, Fujisawa T, Sekino Y, Hosono K, Matsuhashi N, Sakamaki K3, Nakajima A, Kubota K : Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile Duct. Gut Liver. 2017 Jan 15;11(1):149-155. doi: 10.5009/gnl15634.
  21. Fuyuki A, Ohkubo H, Higurashi T, Iida H, Inoh Y, Inamori M, Nakajima A : Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients. J Gastroenterol. 2016 Aug 22. [Epub ahead of print]
  22. Fujita Y, Hasegawa S, Kato Y, Ishii K, Iwasaki A, Sato T, Sekino Y, Hosono K, Nakajima A, Kubota K: Intravenous injection of low-dose flurbiprofen axetil for preventing post-ERCP pancreatitis in high-risk patients: An interim analysis of the trial. Endosc Int Open. 2016 Oct;4(10):E1078-E1082.
  23. Nonaka T, Inamori M, Honda Y, Kanoshima K, Inoh Y, Matsuura M, Uchiyama S, Sakai E, Higurashi T, Ohkubo H, Iida H, Endo H, Fujita K, Kusakabe A, Atsukawa K, Takahashi H, Tateishi Y, Maeda S, Ohashi K, Nakajima A: Can magnifying endoscopy with narrow-band imaging discriminate between carcinomas and low grade adenomas in gastric superficial elevated lesions? Endosc Int Open. 2016 Nov;4(11):E1203-E1210.

↑ PAGE TOP